These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 37817167)

  • 1. Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study.
    Estella Á; Martín-Loeches I; Núñez MR; García CG; Pesaresi LM; Escors AA; Prieto MDL; Calvo JMS
    Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):90. PubMed ID: 37817167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID-19-associated pulmonary aspergillosis.
    Ghazanfari M; Yazdani Charati J; Davoodi L; Arastehfar A; Moazeni M; Abastabar M; Haghani I; Mayahi S; Hoenigl M; Pan W; Hedayati MT
    Mycoses; 2022 Oct; 65(10):960-968. PubMed ID: 35979737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.
    Zhou X; Wu X; Chen Z; Cui X; Cai Y; Liu Y; Weng B; Zhan Q; Huang L
    Front Cell Infect Microbiol; 2023; 13():1287496. PubMed ID: 38076456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
    Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
    PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients.
    Mikulska M; Furfaro E; Dettori S; Giacobbe DR; Magnasco L; Dentone C; Ball L; Russo C; Taramasso L; Vena A; Angelucci E; Pelosi P; Bassetti M
    Mycoses; 2022 Apr; 65(4):411-418. PubMed ID: 35138675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.
    Castillo CG; Kauffman CA; Zhai J; Jiang H; Agozino SM; Miceli MH
    Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
    Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
    Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID-19-associated pulmonary aspergillosis: Cross-sectional and systematic review of literature.
    Dos Santos AP; Amorim BC; da Silva DG; de Rodrigues DKB; da Costa Marques AP; Gasparoto ALDB; da Costa Alvarenga de Brito E; Fava WS; de Oliveira CTF; Canassa AL; Gonçalves CCM; Grande AJ; de Souza Carvalho Melhem M; Paniago AMM; Volpe-Chaves CE; Venturini J
    Mycoses; 2024 Aug; 67(8):e13789. PubMed ID: 39179520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.
    He H; Ding L; Sun B; Li F; Zhan Q
    Crit Care; 2012 Jul; 16(4):R138. PubMed ID: 22835335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnostic performance of galactomannan detection in invasive pulmonary aspergillosis with severe and critically ill influenza].
    Lin PC; Zeng JH; Su SS; Zhou Y; Chen JJ; Chen CS; Li YP
    Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(15):1050-1056. PubMed ID: 33878831
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
    Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study.
    Autier B; Prattes J; White PL; Valerio M; Machado M; Price J; Egger M; Gangneux JP; Hoenigl M
    J Clin Microbiol; 2022 Jan; 60(1):e0168921. PubMed ID: 34643415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis.
    Roman-Montes CM; Martinez-Gamboa A; Diaz-Lomelí P; Cervantes-Sanchez A; Rangel-Cordero A; Sifuentes-Osornio J; Ponce-de-Leon A; Gonzalez-Lara MF
    Mycoses; 2021 Apr; 64(4):364-371. PubMed ID: 33217784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.
    Lahmer T; Neuenhahn M; Held J; Rasch S; Schmid RM; Huber W
    J Crit Care; 2016 Dec; 36():259-264. PubMed ID: 27475024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impact of Bronchoalveolar Lavage Fluid Galactomannan and Aspergillus Culture Results on Survival in COVID-19 Intensive Care Unit Patients: a
    Giacobbe DR; Prattes J; Wauters J; Dettori S; Signori A; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Klimko N; Shadrivova O; Cornely OA; Rautemaa-Richardson R; Koehler P; Lagrou K; Bassetti M; Hoenigl M;
    J Clin Microbiol; 2022 Apr; 60(4):e0229821. PubMed ID: 35321555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
    Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients.
    Eigl S; Prattes J; Lackner M; Willinger B; Spiess B; Reinwald M; Selitsch B; Meilinger M; Neumeister P; Reischies F; Wölfler A; Raggam RB; Flick H; Eschertzhuber S; Krause R; Buchheidt D; Thornton CR; Lass-Flörl C; Hoenigl M
    Crit Care; 2015 Apr; 19(1):178. PubMed ID: 25927915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.